Ms. Mary Ann Zigouris, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2087 Little Rd, Trinity, FL 34655 Phone: 727-815-7205 |
Barbara A Mccormick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9005 Callaway Dr, Trinity, FL 34655 Phone: 727-937-7900 |
Mary K. Godbey, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1135 Halapa Way, Trinity, FL 34655 Phone: 217-572-2091 |
Cassie Koester, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 9332 State Route 54, Suite 307, Trinity, FL 34655 Phone: 727-999-3311 |
Dana Adams Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1819 Short Branch Dr Ste 103, Trinity, FL 34655 Phone: 727-416-1272 |
Lawrence A Silver, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1815 Health Care Dr, Trinity, FL 34655 Phone: 727-232-0735 Fax: 727-232-1824 |
Dr. Edward Augustus Coates, LCSW, ED.D Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6313 Clark Lake Drive, Trinity, FL 34655 Phone: 727-645-6604 |
Ania E Jarmulowicz, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8704 Persea Ct, Trinity, FL 34655 Phone: 727-358-6426 |
News Archive
During the Forum of the African AIDS Vaccine Program (AAVP) in Kampala, Uganda, on Wednesday, Alan Bernstein, the director of the Global HIV Vaccine Enterprise, discussed ongoing efforts to launch an experimental HIV vaccine trial - similar to the recent trial in Thailand - in Africa, the Daily Monitor reports.
Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today.
In a multi-center, randomized, trial across Europe, electroCore's non-invasive vagus nerve stimulation (nVNS) therapy was found to meet its primary endpoint of statistical significance in reducing the number of cluster headache attacks when compared with the standard of care.
New research on the properties of the clot-busting stroke drug tPA (tissue-type plasminogen activator) suggests that tPA can act as a neuroprotectant and may form the keystone of an adaptive response to a reduction in blood flow.
› Verified 3 days ago